Shixuan Wang

3.7k total citations
106 papers, 2.3k citations indexed

About

Shixuan Wang is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Shixuan Wang has authored 106 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 28 papers in Reproductive Medicine and 22 papers in Oncology. Recurrent topics in Shixuan Wang's work include Ovarian cancer diagnosis and treatment (14 papers), Cervical Cancer and HPV Research (13 papers) and Virus-based gene therapy research (11 papers). Shixuan Wang is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Cervical Cancer and HPV Research (13 papers) and Virus-based gene therapy research (11 papers). Shixuan Wang collaborates with scholars based in China, United States and Japan. Shixuan Wang's co-authors include Ding Ma, Jianfeng Zhou, Wei Wang, Aiyue Luo, Gang Xu, Aiwu Fan, Danhui Weng, Meng Li, Yunping Lu and Wei Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Shixuan Wang

100 papers receiving 2.3k citations

Peers

Shixuan Wang
Hua Xiang China
Zhiying He China
Oliver M.T. Pearce United Kingdom
Arnold Pizzey United Kingdom
Sílvia Regina Rogatto Brazil
Petra E. de Ruiter Netherlands
Lucy Ghali United Kingdom
Sarah Netzel–Arnett United States
William K. Decker United States
Odile Sabido France
Hua Xiang China
Shixuan Wang
Citations per year, relative to Shixuan Wang Shixuan Wang (= 1×) peers Hua Xiang

Countries citing papers authored by Shixuan Wang

Since Specialization
Citations

This map shows the geographic impact of Shixuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shixuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shixuan Wang more than expected).

Fields of papers citing papers by Shixuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shixuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shixuan Wang. The network helps show where Shixuan Wang may publish in the future.

Co-authorship network of co-authors of Shixuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shixuan Wang. A scholar is included among the top collaborators of Shixuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shixuan Wang. Shixuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Fengping, Chen Yang, Wenmin Tian, et al.. (2025). mTORC1 regulates autophagosomal components recycling through SNX16 phosphorylation. Proceedings of the National Academy of Sciences. 122(46). e2511069122–e2511069122.
3.
Li, Fei, Quan Wang, Tingting Wang, et al.. (2025). Elastin-like peptides for efficient and safe delivery of mRNA. Journal of Controlled Release. 388(Pt 1). 114337–114337.
4.
Meng, Zijuan, Yuxin Hu, Biao Chen, et al.. (2024). Surface-engineered erythrocyte membrane-camouflage fluorescent bioprobe for precision ovarian cancer surgery. European Journal of Nuclear Medicine and Molecular Imaging. 51(12). 3532–3544. 4 indexed citations
5.
Shen, Yuanming, Beihua Kong, Bairong Xia, et al.. (2023). Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.. Journal of Clinical Oncology. 41(16_suppl). 5556–5556. 1 indexed citations
6.
Li, Fei, Ziwei Chen, Shixuan Wang, & Renchi Yang. (2023). Clinical Study of Lymphocyte Subsets in Patients with BCR/ABL Negative Myeloproliferative Neoplasms. Blood. 142(Supplement 1). 6420–6420. 1 indexed citations
7.
Wang, Shixuan, et al.. (2023). Efficacy of Bispecific Antibody Targeting EpCAM and CD3 for Immunotherapy in Ovarian Cancer Ascites: An Experimental Study. Current Medical Science. 43(3). 539–550. 3 indexed citations
8.
Zhou, Qin, Jingjing Jiang, Li Fang, et al.. (2022). Automatic Measurement of Endometrial Thickness From Transvaginal Ultrasound Images. Frontiers in Bioengineering and Biotechnology. 10. 853845–853845. 10 indexed citations
9.
Zhu, Xin, Wenwen Wang, Qin Zhou, et al.. (2022). Automatic endometrial segmentation in ultrasound images using deep learning. 67–71. 1 indexed citations
10.
Xiong, Jiaqiang, Meng Wu, Jilei Chen, et al.. (2021). Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer. ACS Nano. 15(12). 19756–19770. 210 indexed citations
11.
Wang, Yingmei, Shiqian Zhang, Lihui Wei, et al.. (2020). Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. Journal of Gynecologic Oncology. 31(4). e68–e68. 13 indexed citations
12.
Yuan, Ming, et al.. (2014). Risk factors for recurrence of ovarian endometriomas after surgical excision. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(2). 213–219. 7 indexed citations
13.
Li, Wei, Wei Wang, Yan Li, et al.. (2014). Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78. Oncology Reports. 31(6). 2525–2534. 56 indexed citations
14.
Liao, Shujie, Dongrui Deng, Weina Zhang, et al.. (2012). Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Oncology Reports. 29(1). 95–102. 30 indexed citations
15.
Ma, Xiaoli, Jia Liu, Jiang Wu, et al.. (2010). Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells. Clinical Cancer Research. 16(21). 5165–5176. 11 indexed citations
16.
Xing, Hao, Ting Zhou, Mingfu Wu, et al.. (2010). Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion. BMC Cancer. 10(1). 611–611. 17 indexed citations
17.
18.
Yang, Wanhua, Danfeng Luo, Shixuan Wang, et al.. (2008). TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis. Clinical Cancer Research. 14(17). 5494–5502. 96 indexed citations
19.
Wang, Shixuan. (2007). Expression of plexin-B1 in Human Breast Cancer and Its Relationship with Tumor Lymphatic Metastasis. Zhongliu fangzhi yanjiu. 1 indexed citations
20.
Li, Ning, Jianfeng Zhou, Danhui Weng, et al.. (2007). Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 13(19). 5847–5854. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Xiang Breakdown of academic impact, for papers by Zhiying He Breakdown of academic impact, for papers by Oliver M.T. Pearce Breakdown of academic impact, for papers by Arnold Pizzey Breakdown of academic impact, for papers by Sílvia Regina Rogatto Breakdown of academic impact, for papers by Petra E. de Ruiter Breakdown of academic impact, for papers by Lucy Ghali Breakdown of academic impact, for papers by Sarah Netzel–Arnett Breakdown of academic impact, for papers by William K. Decker Breakdown of academic impact, for papers by Odile Sabido
Rankless by CCL
2026